Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

32 results about "Epidermal keratinocyte" patented technology

Epidermal keratinocytes comprise 90 % of all cells found in the epidermis, the outermost layer of skin. They produce keratin, the intermediate filament, largely responsible for skin’s barrier function. Through their interactions with epidermal melanocytes, keratinocytes obtain melanin and store it as a means...

Camelina sativa plant saccharide extract with anti-inflammatory and antioxidant activity as well as preparation method and application of camelina sativa plant saccharide extract

The invention discloses a camelina plant saccharide extract with antioxidant and anti-inflammatory activity and a preparation method thereof.The preparation method comprises the steps that camelina plants are extracted with water and then subjected to fermentation, enzymolysis, filtration, concentration, alcohol precipitation and secondary filtration, filter residues and filtrate are obtained, the filter residues are subjected to water dissolution, ultrafiltration, concentration and freeze drying, and camelina plant extract I is obtained; the filtrate is subjected to concentration, resin column elution, concentration and freeze drying, a camelina sativa plant extract II is obtained, and the camelina sativa plant extract I and / or the camelina sativa plant extract II are / is camelina sativa plant saccharide extracts; the invention further discloses application of the camelina sativa plant saccharide extract in preparation of anti-inflammatory and / or anti-oxidation cosmetics. The camelina sativa plant saccharide extract disclosed by the invention has relatively good scavenging capacity on DPPH free radicals, hydroxyl free radicals and superoxide anion free radicals, has a certain repairing effect on lipopolysaccharide induced human immortalized epidermal keratinocyte HaCat, and is mild and non-irritant.
Owner:HENAN NAPU BIOTECHNOLOGY CO LTD +1

Application of epidermal growth factor-loaded pseudo-ginseng exosome-like nano-vesicles in wound healing

The invention discloses a pseudo-ginseng exosome-like nano vesicle loaded with an epidermal growth factor / application of the pseudo-ginseng exosome-like nano vesicle in wound healing. The research shows that not all exosome-like nano-vesicles from Chinese herbal medicines capable of promoting wound healing have the effect of promoting wound healing, the action mechanism of the pseudo-ginseng exosome-like nano-vesicles in wound healing is further explored, and the research shows that PNVs can promote the proliferation and migration of an epidermal keratinocyte line, so that the PNVs can be used for promoting the healing of the wound. The treatment can be realized by regulating and controlling the activity of immune cells to promote cell proliferation and migration, and the wound healing effect of the EGF-loaded EGF-coated PNVs is remarkably enhanced, so that the EGF-loaded EGF-coated PNVs have a synergistic effect. The invention not only provides a theoretical basis for deeply researching PELNVs, but also provides a new method and a new idea for treating acute wounds.
Owner:THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN

Actin reorganization inhibitor, phagocytosis inhibitor, stain formation inhibitor containing the inhibitor, and external skin preparation containing the inhibitor

To provide actin reorganization inhibitors and phagocytosis inhibitors, which inhibit the actin reorganization and induction of phagocytosis in epidermal keratinocytes by contacting the epidermal keratinocytes with a fibroblast conditioned medium; to provide stain formation inhibitors containing the inhibitor; and to provide external skin preparations containing the inhibitor.SOLUTION: Provided is an inhibitor that inhibits the actin reorganization and induction of phagocytosis in epidermal keratinocytes by contacting the epidermal keratinocytes with a fibroblast conditioned medium, and contains a specific plant extract or a specific compound as an active ingredient. Also provided are a spot formation inhibitor composed of the inhibitor, and a skin external preparation containing the inhibitor.SELECTED DRAWING: None
Owner:PICASO COSMETIC LAB

Epidermal keratinocyte proliferation promoter, filaggrin mRNA expression promoter, serine palmitoyltransferase mRNA expression promoter, involucrin mRNA expression promoter, and ATP production promoter

To provide agents for promoting epidermal keratinocyte growth, filaggrin mRNA expression, serine palmitoyltransferase mRNA expression, involucrin expression or ATP production by finding substances having excellent activity in promoting epidermal keratinocyte growth, filaggrin mRNA expression, serine palmitoyltransferase mRNA expression, involucrin expression or ATP production.SOLUTION: An epidermal keratinocyte growth promoting agent of the invention comprises one or more effective ingredients selected from the group consisting of 2-ketoglutaric acid, 2-isopropyl malate, inosine 5'-monophosphoric acid, succinic acid, malic acid and pyruvic acid. Also, a filaggrin mRNA expression promotor, a serine palmitoyltransferase mRNA expression promotor, an involucrin expression promotor of the invention comprise, as an effective ingredient, 2-ketoglutaric acid. Further an ATP production promotor of the invention comprises 2-isopropyl malate as an effective ingredient.SELECTED DRAWING: None
Owner:MARUZEN PHARMA

Method for inducing differentiation from pluripotent stem cell to epidermal keratinocyte

[Summary] [Problems] The main purpose of this invention is to provide a technique for inducing an epidermal keratinocyte that can produce a three-dimensional cultured skin model with a multi-layered horny cell layer, from a pluripotent stem cell. [Solution] The present invention is a method for inducing differentiation from a pluripotent stem cell to an epidermal keratinocyte, using a non-detached cell after being treated with a cell detaching agent in the inducing step from the pluripotent stem cell, wherein when applying the epidermal keratinocyte to a three-dimensional cultured skin model, a three-dimensional cultured skin model in which the horny cell layer is multi-layered is obtained.
Owner:KOSE CORPORATION +1

Compound active peptide with skin anti-aging, anti-inflammatory and soothing functions and application of compound active peptide

The invention relates to the technical field of cosmetics, in particular to a compound active peptide with skin anti-aging, anti-inflammatory and soothing functions and application of the compound active peptide. The compound active peptide is prepared from acetyl hexapeptide-1, palmitoyl tripeptide-5, acetyl dipeptide-1 cetyl ester, copper peptide and decarboxylated carnosine hydrochloride. The compound peptide acts on dermal fibroblasts, so that expression of p16 and p21 genes is reduced, and cell cycle arrest is improved; the compound acts on epidermal keratinocytes and dermal fibroblasts and inhibits COX-2 gene expression; the compound peptide acts on epidermal keratinocytes and dermal fibroblasts, and the ROS level is reduced; the compound peptide acts on PC12 cells, inhibits secretion of acetylcholine, blocks transmission of neural signals, and plays a role in immediate wrinkle removal.
Owner:GUANGZHOU SHENGJING SHANGMEI BIOTECHNOLOGY CO LTD

Screening method for skin disease inhibitor

To provide a screening method for novel skin disease inhibitors.SOLUTION: A comparison is made between gene expression 1 in human epidermal keratinocytes after a first culture step of culturing the human epidermal keratinocytes in the presence of Corynebacterium bacteria and gene expression 2 in human epidermal keratinocytes after a second culture step of culturing the human epidermal keratinocytes in the presence of Corynebacterium bacteria and the test substance. The comparison enables evaluation of the skin disease inhibitory effect of the test substance in the human epidermal keratinocytes.SELECTED DRAWING: None
Owner:MANDOM CORP +2

Reagent for inducing retinol-like action and use thereof

Provided is a reagent which has reduced inhibition of differentiation of epidermal keratinocytes, is capable of inducing a retinol-like effect, and is mainly applicable to human skin or the like. The reagent for inducing a retinol-like action according to the present disclosure contains bakuchiol (4-[(1E, 3S)-3-vinyl-3, 7-dimethyl octyl-1, 6-dienyl] phenol).
Owner:ICHIMARU PHARCOS CO LTD

Anti-aging cosmetic composition

The present invention relates to a cosmetic skincare composition, preferably anti-aging, for improving the superficial visual appearance of the skin, giving it a more youthful appearance, comprising an extract of Primrose and an extract of dedifferentiated cells of Pale Iris. The invention also relates to the use of such a combination to inhibit the expression of MMP-2 and MMP-9 in epidermal keratinocytes.
Owner:PATYKA COSMETICS +2

Red camellia extract-containing anti-wrinkle composition for promoting cell energy and application thereof

The invention discloses an anti-wrinkle composition containing a camellia japonica extract and capable of promoting cell energy and an application of the anti-wrinkle composition. The anti-wrinkle composition is prepared from the following components in percentage by mass: 5 to 20 percent of camellia japonica extract, 7.4 to 7.6 percent of flaxseed oil, 0.14 to 0.16 percent of sorbitan trioleate, 0.005 to 0.007 percent of celery seed extract, 0.004 to 0.006 percent of crithmum maritimum extract, 0.003 to 0.004 percent of flaxseed extract and the balance of caprylic / capric triglyceride which is supplemented to 100 percent. The invention further discloses application of the anti-wrinkle composition in promoting synthesis of NAD < + > and ATP in dermal fibroblasts and / or epidermal keratinocytes and / or SIRT3 gene expression and application of the anti-wrinkle composition in preparing cosmetics or skin care products with anti-wrinkle and tightening effects. The composition disclosed by the invention is an oil-soluble composition, is easier to absorb, and can improve the mitochondrial activity through synergistic interaction.
Owner:SHANGHAI FOREST CABIN BIOLOGICAL-TECH CO LTD

HPV (human papillomavirus) infected human epidermal keratinocyte model as well as construction method and application thereof

The invention provides an HPV (human papillomavirus) infected human epidermal keratinocyte model and a construction method and application thereof, and relates to the technical field of molecular biology, an HPV genome is integrated to a KRT5 site of genome DNA (deoxyribonucleic acid) of human epidermal keratinocytes to obtain the HPV infected human keratinocyte model, stable integration and expression of an HPV whole genome are successfully realized, and the HPV infected human keratinocyte model is obtained. The position effect caused by random insertion is avoided, and the genetic stability is ensured; the model has the synergistic expression function of HPV early and late genes, maintains the time sequence of virus gene expression, realizes HPV virus particle assembly, and simulates the complete life cycle of HPV. The technical problem that in the prior art, an infection model cannot simulate the complete life cycle of the HPV is solved.
Owner:广州景旸生物科技有限公司

Stratified squamous epithelial cell normal differentiation and maturation promoting agent, epithelial disease therapeutic agent, and stratified squamous epithelial cell normal differentiation and maturation promoting method

The present invention addresses the problem of providing a novel therapeutic agent that is effective against diseases involving stratified squamous epithelial cells such as dry eye syndrome. The present invention is an agent for promoting normal differentiation / maturation of stratified squamous epithelial cells, which comprises a secretion of mesenchymal stem cells. It is preferable that the secretions not include animal serum, that the mesenchymal stem cells be adipose-derived mesenchymal stem cells, umbilical cord-derived mesenchymal stem cells, or bone marrow-derived mesenchymal stem cells, and that the stratified squamous epithelial cells be at least one selected from the group consisting of corneal epithelial cells, conjunctival epithelial cells, epidermal keratinocytes, oral epithelial cells, epiglottic epithelial cells, esophageal epithelial cells, vaginal epithelial cells, vocal fold epithelial cells, nasal epithelial cells, and nasal vestibular epithelial cells.
Owner:OSAKA UNIVERSITY +1

Moisturizing composition containing Chinese herbal medicine compound

The invention belongs to the technical field of cosmetics, discloses a moisturizing composition containing a Chinese herbal medicine compound, and particularly discloses a traditional Chinese medicine extract compound which comprises the following components: a radix ophiopogonis extract, a radix scrophulariae extract and a chlorella extract. The invention provides a traditional Chinese medicine extract compound prepared from radix ophiopogonis extract, radix scrophulariae extract and chlorella extract, and the traditional Chinese medicine extract compound not only can promote mitochondrial respiration, but also can promote generation of H2O in epidermal keratinocytes and dermal fibroblasts, so that generation of epidermal endogenous moisturizing factors and hyaluronic acid is promoted, and the skin moisturizing effect is improved. And the generation of hyaluronic acid in the dermis is increased, so that the comprehensive moisturizing function of the epidermis and the dermis can be maintained at the same time, and finally, the double-layer multi-moisturizing purpose of surface moisturizing and deep moisturizing is achieved.
Owner:INFINITUS (CHINA) CO LTD

Method for inducing differentiation from pluripotent stem cell to epidermal keratinocyte

[Summary] [Problems] The main purpose of this invention is to provide a technique for inducing an epidermal keratinocyte that can produce a three-dimensional cultured skin model with a multi-layered horny cell layer, from a pluripotent stem cell. [Solution] The present invention is a method for inducing differentiation from a pluripotent stem cell to an epidermal keratinocyte, using a non-detached cell after being treated with a cell detaching agent in the inducing step from the pluripotent stem cell, wherein when applying the epidermal keratinocyte to a three-dimensional cultured skin model, a three-dimensional cultured skin model in which the horny cell layer is multi-layered is obtained.
Owner:KOSE CORPORATION +1

Artificial cultured skin and method for producing the same

To provide an artificial cultured skin with excellent skin tissue (for example, properly formed horny layers and appropriately expressed genes).SOLUTION: An artificial cultured skin comprises: a basal tissue layer, comprising adipose-derived stem cells and a gel; a dermal tissue layer, disposed on the basal tissue layer and comprising fibroblasts and a gel; and an epidermal layer, disposed on the dermal tissue layer and comprising epidermal cells. Preferably, the gel is a collagen gel or a fibrin gel. Preferably, the adipose-derived stem cells are human adipose-derived stem cells. Preferably, the fibroblasts are normal human dermal fibroblasts. Preferably, the epidermal cells are normal human epidermal keratinocytes.SELECTED DRAWING: Figure 1
Owner:THE UNIV OF TOKYO +1

Involucrin mRNA expression promoter, transglutaminase-1 mRNA expression promoter, and filaggrin mRNA expression promoter

To discover, from among compositions of natural origin having high safety, ones having filaggrin mRNA expression promoting action, involucrin mRNA expression promoting action, and transglutaminase-1 mRNA expression promoting action, and provide a filaggrin mRNA expression promoter, an involucrin mRNA expression promoter, and a transglutaminase-1 mRNA expression promoter containing the same as an active ingredient.SOLUTION: A filaggrin mRNA expression promoter, an involucrin mRNA expression promoter, and a transglutaminase-1 mRNA expression promoter, which are used to promote the expression of filaggrin mRNA, involucrin mRNA, and transglutaminase-1 mRNA in epidermal keratinocytes, are made to contain, as an active ingredient, a water extract from the leaf pulp portion of Aloe vera and / or a hydrophilic organic solvent extract from the leaf pulp portion of Aloe vera.SELECTED DRAWING: None
Owner:MARUZEN PHARMA

Small molecule compound and application thereof in preparation of medicine for treating 24p3R-mediated diseases

The invention relates to a small molecule compound and application thereof in preparation of a medicine for treating 24p3R-mediated diseases. The invention relates to an application of small molecule compounds 5509605 and 5318411 or pharmaceutically acceptable salts thereof in preparation of medicines for treating diseases mediated by 24p3R (24p3R), in particular to an application of the small molecule compounds 5509605 and 5318411 in preparation of medicines for treating diseases mediated by 24p3R. According to the technical scheme, the core mechanism of the compound in treatment of 24p3R-mediated skin inflammatory diseases is disclosed for the first time by screening and verifying the targeted regulation effect of a specific small molecule compound on a 24p3R receptor. The small molecule drug can be specifically combined with an active site of a 24p3R receptor protein, and by blocking the combination of 24p3R and LCN2, the activation of an LCN2-SREBP2-NLRC4 signal axis is inhibited, and the expression of proinflammatory factors such as IL1beta, CXCL1 and CCL20 is reduced, so that the pathological proliferation and immune cell infiltration of psoriasis characteristic epidermal keratinocytes are blocked at the molecular level.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Composition comprising a high-pressure treatment of a mixture containing sturgeon eggs

The anti-inflammatory composition promotes proliferation of macrophage and suppresses inflammation caused by inflammatory cytokine and / or NO synthase, and promotes proliferation of human fibroblast or human epidermal keratinocyte and promotes synthesis of hyaluronic acid in epidermis and dermis. To provide a skin-beautifying and promoting composition which keeps the tension of the skin, strengthens the bonding force of the skin, improves the barrier function of the skin, enhances the strength and water-retaining function of the skin surface, or promotes the anti-aging of the skin, to provide a hair-growing composition which promotes the proliferation of human epidermal keratinocyte cells, improves the strength of the skin surface, and promotes hair growth, and to provide cosmetic compositions thereof.SOLUTION: The composition comprises a high-pressure treated product of a mixture of sturgeon eggs and 1, 3-butylene glycol.SELECTED DRAWING: Figure 3
Owner:COSMETIC RES INST CO LTD

Use of compound G414-0147 in preparing a drug for promoting skin wound healing

The present invention discloses the use of compound G414-0147 in the preparation of a drug for promoting skin wound healing, wherein the molecular formula of compound G414-0147 is C 25 H 30 FN7, with the structural formula #imgabs0#, is a small molecule drug proposed in the present invention for use in preparing a drug that promotes skin wound healing. The drug, in particular, contains compound G414-0147 or a pharmaceutically acceptable salt thereof as an active ingredient. The drug promotes skin wound healing by promoting epidermal keratinocyte migration. The drug is highly safe, stable, can treat large-area skin wounds, and has low synthesis cost. This drug provides a new approach for the clinical treatment of skin wound healing and has important clinical application value.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Composition for promoting skin microcirculation, makeup removing cream and preparation method of makeup removing cream

The invention provides a composition for promoting skin microcirculation, makeup removing cream and a preparation method of the makeup removing cream, and relates to the technical field of skin care products. The composition for promoting skin microcirculation comprises an ingredient for inducing vasodilation, an ingredient for improving vascular tolerance, an ingredient for reducing free heme and an ingredient for relieving perceptual pressure, and skin care is realized on the basis of improving forward emotion perception and accelerating blood circulation. Compared with a traditional single microcirculation path, for example, human epidermal keratinocyte and normal vascular endothelial cells are purely promoted to synthesize nitric oxide, a nitric oxide mediated negative feedback loop is activated to stimulate smooth muscle mediated vasodilation, and blood circulation is not obviously promoted. According to the application, the preferable raw material design comprises the steps of inducing vasodilation, preventing a large amount of hemoglobin from permeating out of the skin and then degrading permeated free heme to realize a multi-channel closed loop to promote blood microcirculation, and active matters capable of regulating endokephin secretion are matched to further relax facial muscles and relieve the pressure skin.
Owner:HUNAN YUJIA COSMETICS MFG CO LTD

Dendritic mesoporous silicon nano-material loaded with glucose oxidase as well as preparation method and application of dendritic mesoporous silicon nano-material

The invention belongs to the field of nano medicine, and particularly relates to a dendritic mesoporous silicon nano material loaded with glucose oxidase as well as a preparation method and application of the dendritic mesoporous silicon nano material. Glucose oxidase is loaded on the dendritic mesoporous silicon nano-material by utilizing the electrostatic interaction and pore adsorption effect between the dendritic mesoporous silicon nano-material with negative charges and glucose oxidase with positive charges, and the glucose oxidase is loaded on the dendritic mesoporous silicon nano-material by adjusting the dosage of the glucose oxidase and the dendritic mesoporous silicon. The dendritic mesoporous silicon nano material (DMSN (at) GOx) loaded with the glucose oxidase is obtained. The DMSN-coated GOx can effectively reduce the glucose level and the pH value of the psoriasis site, further reduce the chemotactic factor generation level of keratinocytes, cut off the bridge with immune cells, inhibit the inflammatory factor level of an inflammatory region, effectively relieve the abnormal hyperplasia of the keratinocytes of an epidermal layer and the infiltration of immune cells of a corium layer, and improve the psoriasis treatment effect. The purpose of treating psoriasis is achieved, but no obvious toxicity is caused to normal tissues.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE

Composition for inducing epidermal damage regeneration

The present invention relates to: a composition for regenerating or repairing skin damage and / or promoting epidermal cell differentiation, comprising calcium lactate as an active ingredient; and a method therefor, wherein the skin damage includes that caused by ultraviolet rays. The present invention induces differentiation of epidermal keratinocytes so as to form a biological barrier and allows the skin to maintain moisture on its own, and, as a temporary effect, plays a role in protecting the skin from UV by forming nanoparticles on the surface thereof.
Owner:METIMEDI PHARMA CO LTD

Animal model for researching inflammatory dermatosis mechanism, construction method and application

The invention belongs to the field of drugs for inflammatory dermatosis, and discloses an application of myrcene in preparation of drugs for inflammatory dermatosis, which comprises the following steps: combining a mouse AD model (DNCB) with human epidermal keratinocytes (NHEK) and mouse macrophages (RAW264.7); the improvement effect of the MYR is evaluated by adopting histology and immunofluorescence technologies; by integrating transcriptomics and proteomics analysis, the molecular mechanism of MYR for relieving AD symptoms is clarified, and the causal relationship is verified by using a pharmacological inhibitor. The conclusion of the invention is as follows: Myrcene alleviates AD sample inflammation by inhibiting FAK / Src-YAP / TAZ axis. A repeatable mechanism framework is established by the data, and the natural monoterpenoids are associated with biomechanical-nuclear signal transduction and innate immune regulation in AD.
Owner:SOUTHWEST UNIV

Promoter of new protein synthesis

PendingJP2026115383ABiotechnologyAzadirachta indica leaf extract
Traditional research focusing on protein synthesis has focused on the total amount of protein, and therefore requires components that either suppress the decrease in the amount of newly synthesized protein or promote its synthesis. [Solution] Focusing on the synthesis of new proteins, and utilizing a method for evaluating the amount of new protein synthesis in dermal fibroblasts and epidermal keratinocytes, neem leaf extract and kudzu extract are provided as inhibitors of the decrease in the amount of new protein synthesis or as promoters of new protein synthesis.
Owner:SHISEIDO CO LTD

Method for relieving injury induced by high-dose uvb through low-dose caffeine

The invention discloses a method for relieving damage induced by high-dose UVB (ultraviolet B) through low-dose caffeine. The caffeine with the concentration of 1000ng / ml has a photochemical protection effect on human epidermal keratinocytes (HaCaT) which are irradiated and induced by the UVB with the concentration of 50mJ / cm < 2 >. The caffeine can significantly improve damage of uvb-radiated hacat cells, hacat cell damage is improved by reducing oxidative stress damage, adjusting metabolic reaction, maintaining mitochondrial membrane potential and increasing expression of autophagy-related protein, and the caffeine can improve the activity of the hacat cells, improve mitochondrial aerobic respiration, maintain mitochondrial membrane potential stability and increase autophagy reaction. The caffeine improves the activity of the hacat cells, reduces oxidative stress damage of the hacat cells and accelerates aerobic respiration of mitochondria so as to promote autophagy and play a protection role.
Owner:GENERAL HOSPITAL OF PLA

Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte

[Problems] The main purpose of this invention is to provide a technique for inducing an epidermal keratinocyte that can produce a three-dimensional cultured skin model with a multi-layered horny cell layer, from a pluripotent stem cell.[Solution] The present invention is a method for inducing differentiation from a pluripotent stem cell to an epidermal keratinocyte, using a non-detached cell after being treated with a cell detaching agent in the inducing step from the pluripotent stem cell, wherein when applying the epidermal keratinocyte to a three-dimensional cultured skin model, a three-dimensional cultured skin model in which the horny cell layer is multi-layered is obtained.[Selected Drawing] none.
Owner:KOSE CORPORATION +1

Method for screening an active compound in vitro

The present invention relates to a kit comprising a co-culture microdevice containing peripheral sensory neurons (PSN) and human epidermal keratinocytes (HEK) in a cell culture adapted for both cell types. It is also described a method for screening an active compound using the kit according to the present invention, as well as the use thereof for in vitro drug tests and for producing a cosmetic product for various dermatological applications, such as atopic dermatitis, sensitive skin, photoaging, wound healing and epidermal thickness in aged skin.
Owner:LOREAL SA

Collagen production promoter, hyaluronic acid production promoter, and epidermal keratinocyte activator

The purpose of the present invention is to provide a novel material that promotes the production of collagen and / or hyaluronic acid and / or activates human epidermal keratinocytes. A lactic acid bacterium belonging to the genus Fructobacillus, a culture of the lactic acid bacterium, a culture supernatant of the lactic acid bacterium, and / or an extract of the lactic acid bacterium are useful as active ingredient of a collagen production promoter, a hyaluronic acid production promoter, and an epidermal keratinocyte activator.
Owner:KYUSHU UNIV +1

Compositions comprising niacinamide and resveratrol salicylate

A topical skincare composition that comprises niacinamide and one or more resveratrol salicylates. The compositions increase the levels of energy in epidermal keratinocytes, while mitigating oxidative damage associate with increased ATP production due to application of niacinamide. Also increased is the expression of AQP-3, CLDN-1 and CLDN-4, leading to improved barrier function and increased moisture retention in skin. Preferred compositions are in the form of creams, lotions, serums or gels, implemented as mixtures or emulsions.
Owner:ELC MANAGEMENT LLC

Application of relieving and moisturizing effects of cineole in facial dermatitis rehabilitation

The invention belongs to the technical field of application of cineole, discloses application of relieving and moisturizing effects of cineole in facial dermatitis rehabilitation, and comprises application of cineole in preparation of a medicine for facial dermatitis rehabilitation. The Cin can play an antioxidant role by regulating expression of gene transcription and protein levels of Bax, Bcl-2 and inflammatory factors IL-1beta and regulating ROS, SOD and MDA, and plays a role in protecting H2O2-induced HaCaT cells and menadione-induced oxidative stress of zebrafish, so that the cineole is proved to have a protective role in epidermal keratinocytes under oxidative stress, and the cineole can be used for preparing a medicine for treating the oxidative stress of the zebrafish. Treating zebra fish with sodium chloride, observing the influence of the tail area of the zebra fish, and evaluating the moisturizing effect of Cin; by inhibiting expression of TRPV1 and TRPV4, opening of ion channels is inhibited, nerve impulse conduction is inhibited to play a soothing role, and dermatitis or skin discomfort caused by stimulation of ultraviolet rays, polluted air, drugs and the like on skin can be treated or relieved.
Owner:GUANGZHOU DERMATOLOGY HOSPITAL (GUANGZHOU CENTER FOR SKIN DISEASES & STI CONTROL & PREVENTION)